DUBLIN, Feb. 8, 2024 /PRNewswire/ -- The "Global Markets for Vaccine Technologies" report has been added to
ResearchAndMarkets.com's offering.
Advancements will occur in regard to the development of novel vaccines towards emerging infectious diseases, cancers and allergies. Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth. The global vaccine technologies market is segmented in this report by technology, disease, age, and region. This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.
This report includes only human vaccines; animal vaccines have not been considered in this report. This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.
Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.
This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.
This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.
34 data tables and 63 additional tables
An up-to-date overview of the global markets for vaccine technologies
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and region
Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscape
Assessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization schedule
Discussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companies
Review of patents and patent applications
Overview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture funding
Analysis of the competitive landscape based on recent developments and segmental revenues
Profiles of the leading companies
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Immune System and Vaccines
Components of the Immune System
Cells of the Immune System
Major Histocompatibility Complex (MHC)
Immunization and Vaccines
Disorders of the Immune System
Impact of Lifestyle on the Immune System
Principles of Immunization
Advantages of Vaccination
Vaccines and Immunization, Overview
Attenuated (Live) Vaccines
Inactivated (Killed) Vaccines
Recombinant Vector Vaccines
Advantages of Immunization
World Health Organization (WHO) Prequalified Vaccines
Significant Regulatory Developments in Vaccines
Chapter 4 Market Dynamics
Growing Awareness of Immunization
Growing Investments and R&D
Vaccine Development and Pricing
Increased Demand from Emerging Markets
Advent of mRNA Technology
Impact of COVID-19 on Routine Infant Vaccination Stagnating Global Coverage Rate
Progress and Challenges by Country and Region
Chapter 6 Market Breakdown by Technology
Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
Other/Combination Vaccines
Chapter 7 Market Breakdown by Disease
Chapter 9 Market Breakdown by Region
Chapter 10 Emerging Technologies and Developments
Virus-Like Particle (VLP) Vaccines
Self-Amplifying RNA Vaccines
AI and Computational Biology
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/squdpk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets